Vuxen Group AB (HERNO-B) fair value: what the stock is really worth
As of Oct 20, 2026: fair value (intrinsic value) of Vuxen Group AB stock SEK 1.73, price SEK 3.09, upside -44.0%, quality 46 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
28‑month range kr 2.91 – kr 7.96 · fair‑value band kr 1.21 – kr 2.25 · the kr 3.09 price screens above the kr 1.73 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 3, 2026.
Follow Vuxen Group in your weekly email
Every Wednesday you see whether Vuxen Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Hernö Gin AB (publ) produces and sells gins in Sweden and internationally. The company offers various cocktails. It also operates bar and hotel under the Hernö Gin brand name. The company was incorporated in 2011 and is based in Härnösand, Sweden.
Stock analysis
Vuxen Group AB (HERNO-B) currently trades at kr 3.09, while our model-based Fair Value estimate is kr 1.73, 44.0% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of kr 1.85 per share, and 1 of the 12 models we run sit above the kr 3.09 price.
Bear case: the Asset-Based group reads lowest at kr 0.4000, and 11 of the 12 models stay below the price. Data coverage for this calculation is low.
Scenario range: kr 1.21 (bear) to kr 2.25 (bull), the price of kr 3.09 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 46/100 (below-average quality), in the Consumer Defensive sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
Vuxen Group AB reported revenue of 47.4M SEK in FY2025 versus 37.1M SEK in FY2021, a compound +6.3%/yr. Reported net income was 4.4M SEK in FY2025, compounding −16.8%/yr from FY2021.
Key figures
Market cap 126M SEK (≈ $12.7M) Micro · P/E ratio 318.0 · P/S ratio 29.8 · EPS (TTM) kr 0.0100 · Net margin 9.4% · Return on assets (EBIT) 11.5% · Free cash flow −618K SEK.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).
What moves the price
The share trades about 15% below its 52-week high and 6% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at 25% fair-value upside, at −44%, HERNO-B screens richer than that median.
Fair Value models
Bearkr 1.21Fair Value kr 1.73Bullkr 2.25
Price kr 3.09 · Upside -44.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (kr 0.0080 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.15/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
−5.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.9%
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−13.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−13.7%
Dividend (yield on the price)0.0%
Profit margin 2021 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.32% → 8%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Beverages - Wineries & Distilleries · 90 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Vuxen Group AB Fair Value". https://www.fairvalue-calculator.com/stock/HERNO-B
Frequently asked questions
Is Vuxen Group AB (HERNO-B) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of kr 1.73 versus a price of kr 3.09, about −44% upside (overvalued).
What is the fair value of HERNO-B?
Our model-based fair value for Vuxen Group AB is kr 1.73 (as of Oct 3, 2026), built from audited fundamentals. The current price: kr 3.09.
What is the quality score of HERNO-B?
Vuxen Group AB has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Vuxen Group AB (HERNO-B)?
Our model-based price target is the fair value of kr 1.73 (as of Oct 3, 2026) from 12 valuation models. Cautious scenario kr 1.21, optimistic scenario kr 2.25. It is a calculation from audited fundamentals, not an analyst target.
What is the Vuxen Group AB stock forecast for 2026?
Our models put fair value at kr 1.73, about −44% upside versus a price of kr 3.09 (overvalued). Cautious scenario kr 1.21, optimistic scenario kr 2.25. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Vuxen Group AB (HERNO-B)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Vuxen Group AB it is kr 1.73 per share (as of Oct 3, 2026), against a price of kr 3.09. It is the blended result of 12 valuation models (cash flow, earnings, asset, dividend).
Is Vuxen Group AB stock overvalued or undervalued in 2026?
As of Oct 3, 2026, HERNO-B trades above its calculated fair value: price kr 3.09, fair value kr 1.73, a gap of about −44% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of HERNO-B?
No. The price is what the market pays today (kr 3.09); the fair value is what the company's own numbers justify (kr 1.73). For Vuxen Group AB the two are kr 1.36 per share apart. That gap is exactly why we show both numbers side by side.
How much is Vuxen Group AB worth?
The market values Vuxen Group AB at about 126M SEK (market capitalisation, as of Oct 3, 2026). Per share that is kr 3.09; our models calculate a fair value of kr 1.73 per share.
What do the bullish and bearish scenarios say about HERNO-B?
Our models span a range for Vuxen Group AB: cautious scenario kr 1.21, base kr 1.73, optimistic kr 2.25 per share (as of Oct 3, 2026, price kr 3.09). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of HERNO-B?
Vuxen Group AB trades at a price-to-earnings ratio of 318.0 (as of Oct 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of kr 1.73 is built from several models across several years. Other multiples: P/B 0.1, EV/EBITDA 0.5.
How far is HERNO-B from its 52-week high?
Vuxen Group AB trades at kr 3.09, about 15% below its 52-week high of kr 3.64 and 6% above the low of kr 2.91 (as of Oct 20, 2026). Distance from the high says nothing about value: that is what the fair value of kr 1.73 is for.
Which stocks are comparable to Vuxen Group AB?
From the same area (Consumer Defensive) we also value Kweichow Moutai Co, Wuliangye Yibin Co, Shanxi Xinghuacun Fen Wine Factory Co, Pernod Ricard SA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Vuxen Group AB stock attractive at the current price?
The data as of Oct 3, 2026: price kr 3.09, calculated fair value kr 1.73 (−44%), Quality Score 46/100, from 12 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of HERNO-B calculated?
We run Vuxen Group AB through 12 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 1.73, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.9 % above its aggregate fair value. Vuxen Group AB itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Vuxen Group AB (HERNO-B)?
The closing price on Oct 20, 2026 was kr 3.09. Our model-based fair value is kr 1.73, about −44% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Vuxen Group AB right now?
The price sits above even our optimistic bull case (kr 2.25). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (46/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (kr 1.21 to kr 2.25) leaves room in how you read the outcome.
Key figures of Vuxen Group AB
How large is the market capitalisation of Vuxen Group AB (HERNO-B)?
The market capitalisation of Vuxen Group AB is 126M SEK (≈ $12.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Vuxen Group AB (HERNO-B)?
The price-to-sales ratio of Vuxen Group AB is 29.8 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Vuxen Group AB (HERNO-B)?
Earnings per share at Vuxen Group AB are kr 0.0100 (price ÷ EPS = P/E 318.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Vuxen Group AB (HERNO-B)?
The net margin of Vuxen Group AB is 9.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Vuxen Group AB (HERNO-B)?
On an EBIT basis the return on assets of Vuxen Group AB is 11.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much free cash flow does Vuxen Group AB (HERNO-B) generate?
The free cash flow of Vuxen Group AB is −618K SEK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch Vuxen Group AB in the live analysis
One click puts Vuxen Group AB on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Thin data
Oct 3, 2026